News

- News
NeuraLight Nominated for the 2025 Prix Galien USA Award in Digital Health

Oct 27, 2025
- News
NeuraLight and CHDI Foundation Collaborate to Advance Precision Eye Movement Biomarkers for Huntington’s Disease

Sep 9, 2025
- News
Renowned Parkinson’s Expert Prof. Olivier Rascol Appointed to Lead NeuraLight’s Scientific Advisory Board

Jul 6, 2025
- News
NeuraLight Presents Results on Parkinson’s Progression at IAPRD 2025

May 19, 2025
- News
NeuraLight launches the PARATROOPER trial to advance the understanding of Oculometric Biomarkers in Parkinsonian Disorders

Dec 6, 2024
- News
NeuraLight presents at the International Parkinson and Movement Disorder Society (MDS) Congress 2024

Oct 2, 2024
- News
NeuraLight recognized among World’s Best Digital Health Companies in 2024

Sep 14, 2024
- News
PALOMA Study Launches to Explore Oculometric Biomarkers in Parkinson’s Disease

Aug 21, 2024
- News
NeuraLight presents at the International Parkinson and Movement Disorder Society (MDS) Congress 2023

Sep 1, 2023
- News
A longitudinal trial launched to evaluate change over time in oculometric Biomarkers in Parkinson’s Disease

May 19, 2023
- News
NeuraLight Wins SXSW Innovation Award in Health and MedTech

Mar 13, 2023
- News
NeuraLight Joins the RADIEMS cohort longitudinal Study at Mount Sinai Multiple Sclerosis center

Nov 20, 2022

PARTNERSHIPS

Partner with us to accelerate your CNS drug development

Contact Us